The Ulutas Medical Journal · ISSN 2149-0430 (印刷版), 2149-388X (在线版) · https://www.ulutasmedicaljournal.com/?mno=244932
社论 · 开放获取
致编辑的信:FDG-PET/CT乳腺癌评价
标题、摘要和全文为机器翻译。 英文原文
- Toros University, Vocational School, Department of Medical Imaging Techniques ROR
- 开放获取
- CC BY-NC 4.0
- ORCID
- 资助
- 伦理批准
- 数据可用性
摘要
我强烈建议在手术前在BC患者中进行FDGPET/CT,用于中转、预后评估,以及使用基线图像,以便与模型进行比较。 后续FDG-PET/CT图像.
关键词
全文
全文为机器翻译；以英文原文为准。 英文原文
我想从乳腺癌诊断成像的角度作出一些重要贡献。 BC的手术治疗决定,包括修正性乳房切除术和乳房保存手术,取决于关于BC实际范围的确切数据,特别是元静脉输液管淋巴结的存在。 洛可可地区民族解放军主要指直线民族解放军,但也指其他地方民族解放军,包括国内民族解放军、超民族解放军和基层民族解放军。 (1)。 。 。
虽然乳房X光照相、美国和磁共振成像是BC初始成像中的标准方法,但人们并不认为它们是精确演示元静脉LN的正确工具 (2)18-氟脱氧葡萄糖(FDG)-positron排放成像仪/复合成像仪(PET/CT)被定义为BC患者初步中转的标准和基本方法,因为它在示范元静态地液态液态中的价值 (3). FDG-PET/CT也提供有关预后的重要信息. 与其他成像方法相比,只有FDG-PET/CT才能为肿瘤学家和外科医生保持两个不可替代的定量参数:肿瘤(SUVmax-T)的最大标准化摄入值和元LN(SUVmax-LN)的SUVmax,分别用于证明肿瘤质量和LN的FDG摄入量. 发现在BC频发患者中,SUVmax-T明显较高 (4) 和不良的预测 (5). SUV max-T允许通过量化肿瘤侵犯性来评估BC中的预后.
作为预后的另一个预测者,治疗前的SUVmax-LN可以作为疾病自由生存的决定因素. (6)在预测遥远的变异和存活率下降的可能性方面,有镇静剂的LN特别重要。 (7)FDG-PET/CT也优于常规成像工具,用于展示IM LN中的元数据 (8)然而,还应铭记的是,由于PET的几何分辨率有局限性,微元数据不能被负FDG-PET/CT所排除。 (9)。 。 。
最后,我强烈建议FDG-PET/CT在手术前在BC患者中进行,用于中转、预后评估和基线图像,这些图像将用于与后续FDG-PET/CT图像进行比较。
声明
- 作者贡献（CRediT）
- 所有作者对全部 14 项 CRediT 角色贡献均等（Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing）。
- 资助
-
Funding information was not reported in the published version of this article.
- 利益冲突
- A conflict of interest statement was not reported in the published version of this article.
- 伦理批准
- Ethics committee approval was not required for this article, as it is based on previously published literature and does not involve human participants, patient data or animals.
- 数据可用性
- Data sharing is not applicable to this article as no new data were created or analysed in this study.
参考文献 (9)
9 条参考文献中有 8 条已链接 DOI。
- Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, et al. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics 2002; 22: 5−17. DOI Crossref PubMed Google Scholar
- Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G, et al. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 2008; 26: 4746−51. DOI Crossref PubMed Google Scholar
- Koolen BB, Olmos RAV, Elkhuizen PH, Vogel WV, Peeters MJ, Rodenhuis S, et al. Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy. Breast Cancer Res Treat 2012; 135: 231−40. DOI Crossref PubMed Google Scholar
- Zhang X, Wu F, Han P. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited. Hell J Nucl Med 2014; 17: 177−83. PubMed Google Scholar
- Koolen BB, Peeters MV, Wesseling J, Lips EH, Vogel WV, Aukema TS, et al. Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging 2012; 39: 1830−38. DOI Crossref PubMed Google Scholar
- Song BI, Lee SW, Jeong SY, Chae YS, Lee WK, Ahn BC, et al. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer. J Nucl Med 2012; 53: 1337−44. DOI Crossref PubMed Google Scholar
- Yao MS, Kurland BF, Smith AH, Schubert EK, Dunnwald LK, Byrd DR, et al. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol 2007; 14: 2985−93. DOI Crossref PubMed Google Scholar
- Choi YJ, Shin YD, Kang YH, Lee MS, Lee MK, Cho BS, et al. The effects of preoperative (18)F-FDG PET/CT in breast cancer patients in comparison to the conventional imaging study. J Breast Cancer 2012; 15: 441−48. DOI Crossref PubMed Google Scholar
- Liu Y. Role of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer. World J Clin Oncol 2014; 5: 982−89. DOI Crossref PubMed Google Scholar
阅读全文
在此打开 PDF
正在加载 PDF…
若 PDF 未在此显示，请使用上方的下载按钮。
如何引用本文
Ayaz S. Letter to editor: FDG-PET/CT evaluation of breast cancer. Ulutas Med J. 2016;2(3):157-158. doi:10.5455/umj.20161007125238
Ayaz, S. (2016). Letter to editor: FDG-PET/CT evaluation of breast cancer. The Ulutas Medical Journal, 2(3), 157–158. https://doi.org/10.5455/umj.20161007125238
Ayaz, S. (2016) 'Letter to editor: FDG-PET/CT evaluation of breast cancer', The Ulutas Medical Journal, 2(3), pp. 157–158. doi: 10.5455/umj.20161007125238.